Share this
by Neoteryx Microsampling on December 3,2025
Ringwood, Australia — 4 December 2025 — Trajan Scientific and Medical is pleased to announce the appointment of AppMed Inc. as its distributor in Canada for Trajan’s innovative microsampling portfolio, including the patented Mitra® device with VAMS® technology and the Harpera® Microbiopsy Punch.This strategic distribution agreement enables AppMed to market, sell, and support Trajan’s microsampling solutions across the Canadian healthcare landscape, with a focus on research institutions, clinical laboratories, and decentralized care programs.
Based in Québec, AppMed Inc. is a leading digital health company dedicated to advancing personalized treatment optimization through cutting-edge pharmacokinetic modeling, therapeutic drug monitoring (TDM), and innovative remote patient engagement solutions that support continuous monitoring and medication adherence.
By integrating Trajan’s state-of-the-art microsampling technologies into its clinical service offering, AppMed Inc. will expand access to accurate, low-burden sample collection, empowering healthcare providers to make more informed, individualized dosing decisions while advancing the adoption of precision medicine in Canada.
Mitra®, powered by VAMS® technology and registered with Health Canada, enables precise, low-volume dried biospecimen collection, supporting both in-clinic and remote workflows for therapeutic drug monitoring, clinical trials, and population health programs.
As a complementary technology for skin sampling within Trajan’s microsampling portfolio, the Harpera™ Microbiopsy Punch provides a virtually painless, anesthesia-free alternative to traditional skin biopsies by collecting tiny tissue samples without sutures or visible scarring—for molecular dermatology and inflammatory skin research, particularly well-suited for longitudinal studies.
Designed for use by healthcare professionals and available as an investigational use-only (IUO) product in Canada, Harpera promotes high patient compliance and decentralized skin sampling with rapid healing.
Together, these technologies expand access to accurate, low-burden sample collection, enabling laboratories and healthcare providers across Canada to adopt more flexible, scalable, and patient-friendly workflows.
A Strategic Collaboration for Canadian Clinical Labs
“AppMed’s strong relationships with Canadian laboratories and their commitment to technical support make them a natural fit for Trajan,” said Corinna Rockenbach, Vice President- Clinical Workflows, Trajan Scientific and Medical. “Together, we can help more labs transition to modern microsampling methods that increase access, reduce burden on patients, and streamline workflows.”
“We are proud to partner with Trajan to bring these transformative microsampling technologies to the Canadian market,” said Martin Noël, Chief Executive Officer, AppMed Inc. “At AppMed, our focus is on advancing precision medicine through digital tools, therapeutic drug monitoring, and remote care. The integration of Mitra® and Harpera® into our offering will enhance our ability to support healthcare providers in delivering individualized, data-driven treatment, whether in the clinic or at home.”
Now Available Across Canada! AppMed will provide sales, training, and support for Mitra® and Harpera® products across Canada. Customers can contact AppMed directly to request a demo, receive implementation guidance, or place an order.
Contact Information
AppMed
Website: www.appmed.ai
Email: info@appmed.ca
Phone: 1-888-277-3660
Trajan Scientific and Medical
Website: www.neoteryx.com & www.trajanscimed.com
About Trajan Scientific and Medical
Trajan Scientific and Medical is a global developer and manufacturer of analytical and life sciences technologies dedicated to improving human well-being. Through its Neoteryx® product brand, including Mitra® and Harpera®, Trajan is advancing microsampling solutions that enable decentralized, personalized, and patient-centric healthcare.
Trajan’s CHRONECT™ automation platform extends these microsampling innovations by delivering end-to-end, fully automated microsampling workflows for clinical laboratories. These solutions integrate sample collection, accessioning, and analysis, offering the same convenience and efficiency labs expect from traditional clinical analyzers, while supporting modern, decentralized testing models.
Together, these technologies are transforming the clinical healthcare landscape, enhancing patient access, improving laboratory efficiency, and driving sustainable business outcomes across the diagnostics ecosystem.
About AppMed
AppMed Inc. is a Canadian digital health company dedicated to optimizing medication dosing for hard-to-manage therapies. Through its innovative web-based platform, AppMed® offers advanced tools for pharmacokinetic modeling, therapeutic drug monitoring (TDM), and remote patient monitoring.
AppMed® empowers healthcare providers to deliver personalized, data-driven care while enhancing patient engagement, clinical outcomes, and treatment adherence.
With a focus on decentralized care and precision medicine, AppMed® is redefining how complex treatments are monitored and adjusted across various therapeutic areas.
No Comments Yet
Let us know what you think